The first human trial of a drug candidate that uses nanoform technology with Nanoform Finland‘s proprietary CESS® technology will begin before the year-end of 2020. According to the company, the results from the trial are expected before the end of Q2/2021.
Zydus Pharms USA Inc.'s Generic Piroxicam Receives Approval In The US
Laboratorios Cinfa`s Generic Piroxicam Receives Approval In US
Strides Pharma’s Generic Piroxicam Receives Approval In US
Micro Labs`s Generic Piroxicam Receives Approval In US
Hikma Pharms Generic Piroxicam Receives Approval In Us
Anvisa Suspends and Interdicts 13 Batches of Medicines
NEW DELHI: Drug firm Unichem LaboratoriesBSE 1.35 % today said it has received approval from the US health regulator for Piroxicam Capsules, used in treatment of osteoarthritis and rheumatoid arthritis, in the US market.
Widely used non-steroidal anti-inflammatory drugs (NSAIDs) are associated with an increased risk of heart failure - even in people without a history of cardiac issues, a recent study suggests.
Flamingo Pharms Generic Piroxicam Approved In US